Lunai Bioworks Inc.
LNAI
$1.25
-$0.01-0.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -39.75% | -5.29% | |||
| Depreciation & Amortization | 27.30% | 1.88% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.80% | -1.17% | |||
| Operating Income | 39.80% | 1.17% | |||
| Income Before Tax | 102.22% | -67,083.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 102.22% | -67,083.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 102.22% | -67,083.19% | |||
| EBIT | 39.80% | 1.17% | |||
| EBITDA | 40.34% | 1.19% | |||
| EPS Basic | 101.74% | -61,604.27% | |||
| Normalized Basic EPS | 53.28% | 9.01% | |||
| EPS Diluted | 101.74% | -62,673.91% | |||
| Normalized Diluted EPS | 53.28% | 8.14% | |||
| Average Basic Shares Outstanding | 27.87% | 8.49% | |||
| Average Diluted Shares Outstanding | 27.87% | 7.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||